ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF

SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF

Bispecific EGFR/C-Met Antibodies

METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS

BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS

COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

ACETIC ACID AND HYPOCHLOROUS ACID COMPOSITIONS FOR TREATMENT OF SKIN TRAUMA

PROCESSES FOR GENERATING ENGINEERED CELLS AND COMPOSITIONS THEREOF

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

COMPOSITIONS COMPRISING LOPINAVIR AND TREATMENT OF CONDITIONS

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA

IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

METHODS FOR TREATING CANCER

METHODS FOR TREATING CANCER

CONTROLLED DRUG RELEASE FROM ELECTROSPUN FIBERS

COMPOSITIONS USING IRON EXCIPIENTS AND THEIR USES INCLUDING FOR THE TREATMENT OF CANCER

GENETICALLY MODIFIED NK-92 CELL LINE

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS

RILUZOLE PRODRUGS AND THEIR USE

PREPARATIONS FOR CONTROLLED-RELEASE OF HYPOCHLOROUS ACID

CONTRACEPTIVE COMPOSITIONS AND METHODS FOR IMPROVED EFFICACY AND MODULATION OF SIDE EFFECTS

TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME

METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM

PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

SYSTEMS AND METHODS FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR INHIBITING KINASES

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

METHODS FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

COMBINATIONS AND USES THEREOF

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE

CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION

Carrier-Binding Agent Compositions and Methods of Making and Using the Same

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

Mutant Peptides And Methods Of Treating Subjects Using The Same

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

Compositions And Methods For Reducing Major Adverse Cardiovascular Events

TRIPLE COMBINATION ANTIBODY THERAPIES

METHOD FOR INDUCING WEIGHT LOSS IN A TYPE 2 DIABETES MELLITUS PATIENT

GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

METHODS FOR TREATING NEUROBLASTOMA

Anti-CTLA-4 Antibodies and Uses Thereof

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME

PHARMACEUTICAL COMBINATION CONTAINING ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF

METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

Active Metabolites of Kinesin Spindle Protein Inhibitor Conjugates

TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

TREATMENT OF MITOCHONDRIAL DISEASES

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

Compositions of Azadirachta Indica and Methods of Treating Cancer

METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS

METHOD FOR TREATING TAUOPATHY IN THE BRAIN, BRAIN STEM AND SPINAL COLUMN

GENETICALLY ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME

METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES

PREVENTION OF PROGRESSIVE HEART FAILURE

ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

BIOORTHOGONAL COMPOSITIONS

COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH

COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

METHODS OF TREATING MIGRAINE

IL-8 INIHIBITORS FOR USE IN THE TREATMENT OF SOME UROLOGICAL DISORDERS

ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR

ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

IMMUNOGENIC ANTIGEN IDENTIFICATION FROM A PATHOGEN AND CORRELATION TO CLINICAL EFFICACY

COMBINATION OF A PD-1 ANTAGONIST AND A VEGF-R/FGFR/RET TYROSINE KINASE INHIBITOR FOR TREATING CANCER

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

Combination Treatment

COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY

METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING N-ACETYL-L-TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS

CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION

INHIBITORS OF BRUTON'S TYROSINE KINASE

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS

AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS

SUBSTITUTED ESTERS CONTAINING POLYOLS AND SACCHARIDES FOR TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

ANTIBACTERIAL COMPOSITIONS

COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS

COMPOSITIONS AND METHODS OF TREATING SARCOMA LUNG METASTASIS

RUFINAMIDE FOR USE IN THE TREATMENT OF MYOTONIA

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

AGENT FOR USE IN THE TREATMENT OF GLIOMA

Immune checkpoint inhibitor combinations

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS

COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME

FORMULATIONS OF MILCICLIB AND THERAPEUTIC COMBINATIONS OF THE SAME FOR USE IN THE TREATMENT OF CANCER

CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

FORMULATIONS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER

Combination Therapy with AXL Inhibitor and Immune Checkpoint Modulator or Oncolytic Virus

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE

METHODS SUITABLE FOR DISRUPTING A BIOFILM, AND/OR KILLING BACTERIA CONTAINED IN A BIOFILM

METHODS SUITABLE FOR THE TREATMENT OF ACNE

COMPOSITION COMPRISING COMBINATION OF RAPAMYCIN AND METFORMIN AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES

Adjuvant treatment of HER2-positive breast cancer

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

AMINONAPHTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES

PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE

CURCUMIN AND TURMERONE COMPOSITIONS & METHODS OF USE THEREOF

HEMATOPOIETIC STEM CELLS IN COMBINATORIAL THERAPY WITH IMMUNE CHECKPOINT INHIBITORS AGAINST CANCER

Combination Therapy for Metastatic Cancer

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

COMPOSITION FOR INHIBITING ANTI-CANCER DRUG RESISTANCE

AN ELASTOMERIC ARTICLE

TREATMENT OF HYPOPARATHYROIDISM

THE THERAPEUTIC REGIMEN

METHODS FOR TREATING NEUROBLASTOMA

Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects

Method for supporting memory function and/or cognitive function

DRUG DELIVERING STRETCH RING

Treatment of Constipation-Predominant Irritable Bowel Syndrome

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

Method for Side Effect Reduction in the Use of Statins Via Physiologically Synthesized Glutathione

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA

Collagen peptide-based medicament compositions and devices and methods of production and use thereof

METHODS FOR TREATING CANCER

METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM

Compositions and methods for treatment of homocystinuria

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

METHODS FOR TREATING CANCER

DIAGNOSTIC METHODS FOR T CELL THERAPY

Altering microbial populations and modifying microbiota

METHODS FOR TREATING AND PHARMACEUTICAL COMPOSITIONS

COMPOSITIONS AND METHODS RELATING TO CANCER

METHODS AND COMPOSITIONS RELATING TO BISPECIFIC ANTI-CHI3L1 ANTIBODY REAGENTS

REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS

PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE

HETEROCYCLIC COMPOUNDS AND USES THEREOF

TOPICAL SKIN TREATMENT COMPOSITION

Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS

METHODS AND COMPOSITIONS FOR EXTENDING LIFESPAN

SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS

METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS

COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE

Lipid Disulfide Prodrugs and Uses Related Thereto

Controlled drug release from electrospun fibers

NUTRITIONAL COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES AND NUCLEOTIDES AND USES THEREOF FOR TREATING AND/OR PREVENTING ENTERIC VIRAL INFECTION

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION

METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

Combined Therapy Against Cancer

MACROCYCLIC COMPOUND AND USES THEREOF

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

RILUZOLE PRODRUGS AND THEIR USE

Riluzole prodrugs and their use

FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

PHARMACOKINETICS OF NMDA RECEPTOR ANTAGONISTS

Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids

POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF

Compositions And Methods For Treating Autism

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

DRUG RELEASING COATINGS FOR BALLOON CATHETERS

Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS

REDUCED SEDATION AND DISSOCIATION IN TREATING NEUROLOGICAL DISORDERS

Treatment of Constipation-Predominant Irritable Bowel Syndrome

DEUTERATED ANALOGS OF ETIFOXINE, THEIR DERIVATIVES AND USES THEREOF

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Therapeutic bacteriophage compositions for treating infection

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

METHODS OF TREATING SUICIDALITY

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME

Mutant Peptides And Methods Of Treating Subjects Using The Same

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief

Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief

Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

TOPICAL PREPARATIONS

Subcutaneously administered anti-IL-6 receptor antibody

COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT THEREOF, AND USE THEREOF

THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER

Compositions and methods for inhibiting kinases

COMPOSITIONS AND METHODS COMPRISING CLOSTRIDIUM BUTYRICUM FOR THE TREATMENT OF CANCER

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

Antibiotic formulations for lower back pain

Collagen peptide-based medicament compositions and devices and methods of production and use thereof

Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Prevention of progressive heart failure

Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

D glutamate polyglutamated antifolates and uses thereof

TRACE ELEMENT SOLUTION

COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING FATTY LIVER DISEASE, DIABETES AND HYPERLIPIDEMIA

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

METHODS FOR FORMING A MATRIX FOR RECEIVING TISSUE SAMPLES

PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS

CANCER TREATMENT

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

Triple combination antibody therapies

REDUCING SIDE EFFECTS OF NMDA ANTAGONISTS

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

Treatment of mitochondrial diseases

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TREATING BIOFILMS

BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS

Combination therapy

COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA

Antibody drug conjugates with enzymatically cleavable groups

2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME

Compositions and methods for treatment of pre-cancerous skin lesions

Specific nutritional or therapeutic agent including a mixture of grape and blueberry

Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases

Riluzole prodrugs and their use

COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS

Adjuvant treatment of HER2-positive breast cancer

METHOD FOR PREVENTING OR TREATING GASTROINTESTINAL DISTRESS IN HUMANS USING MASTIC GUM COMPOSITIONS

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

METHODS OF TREATING HIV-1 INFECTION

Prodrugs of riluzole and their method of use

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

ACETIC ACID AND HYPOCHLOROUS ACID COMPOSITIONS FOR TREATMENT OF SKIN TRAUMA

Blended cannabis compounds and methods of making the same

COMPOSITIONS AND METHODS FOR AERODIGESTIVE TREATMENT

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

Polyglutamated antifolates and uses thereof

ANTIVIRAL COMPOUNDS

Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders

Compositions and methods for treating diseases of the nail

GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS

Methods of generating, repairing and/or maintaining connective tissue in vivo

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

CD200 inhibitors and methods of use thereof

PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN

MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS

TOPICAL ERYTHROPOIETIN FORMULATIONS AND METHODS FOR IMPROVING WOUND HEALING WITH AND COSMETIC USE OF THE FORMULATIONS

METHODS FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER

Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

LIQUID DRESSING COMPOSITIONS AND THEIR USES

Preparations for controlled-release of hypochlorous acid

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF

CELL PREPARATION FOR EXTEMPORANEOUS USE, USEFUL FOR HEALING AND REJUVENATION IN VIVO

TDO2 Inhibitors

DRUG RELEASING COATINGS FOR MEDICAL DEVICES

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTS

COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

Collagen peptide-based medicament compositions and devices and methods of production and use thereof